Belvedere Trading
AVXL icon

Belvedere Trading’s Anavex Life Sciences AVXL Stock Holding History

Belvedere Trading’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,000
Closed -$39.2K – 755
2025
Q4 		$39.2K Buy
+11,000
New +$67.4K ﹤0.01% 676
2025
Q1 		– Sell
-23,000
Closed -$247K – 704
2024
Q4 		$247K Hold
23,000
– – ﹤0.01% 373
2024
Q3 		$131K Sell
23,000
-1,000
-4% -$5.77K ﹤0.01% 425
2024
Q2 		$101K Hold
24,000
– – ﹤0.01% 439
2024
Q1 		$122K Sell
24,000
-2,300
-9% -$12.9K ﹤0.01% 403
2023
Q4 		$245K Sell
26,300
-1,800
-6% -$12.4K ﹤0.01% 293
2023
Q3 		$184K Buy
28,100
+1,400
+5% +$11.1K ﹤0.01% 233
2023
Q2 		$217K Buy
+26,700
New +$229K ﹤0.01% 296
2023
Q1 		– Sell
-20,200
Closed -$187K – 938
2022
Q4 		$187K Buy
+20,200
New +$216K ﹤0.01% 357

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM